IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Brooks Laboratories IPO is a Book Building IPO listing on BSE,NSE exchange, with an ipo size of ₹ 63.00 Cr. The company is based in Punjab and caters to Pharmaceutical sector. D And A Financial Services is the merchant banker of Brooks Laboratories IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 25th November 2010.
Brooks Laboratories IPO open date is 16th August 2011 and close date is 18th August 2011. IPO Allotment Date is 30th November -0001 and Listing date is 5th September 2011.
IPO
Size:
₹ 63.00 Cr.
Avg IPO Size (Sector Based)
: ₹
1,431.30 cr.
Sector: Pharmaceutical
IPO so far:
23
Merchant Banker:
D And
IPO by BRLM so far:
2
City:
Punjab
IPO so far:
2
Revenue (annualised):
₹
53.20
cr. 
PE
Ratio:
17.33x
Average Sector PE Ratio: 27.10x
Brooks Laboratories IPO size is ₹ 63.00 Cr. with IPO price of ₹ 100.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
D And A Financial Services Private Limited is the book-running lead manager of the Brooks Laboratories IPO. Link Intime India Private Limited is the Registrar for Brooks Laboratories IPO.
Brooks Laboratories IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Brooks Laboratories IPO, based in Punjab, operates in the Pharmaceutical sector with a focus on business of Pharmaceutical Contract Research & Manufacturing. The company is launching its MainBoard IPO on the BSE,NSE exchange, using the Book Building Issue method. Brooks Laboratories IPO size is ₹ 63.00 Cr. with fresh issue size of ₹ 63 Cr. and Offer for sale being ₹ Nil
The IPO allotment date for Brooks Laboratories IPO is expected to be 30th November -0001, after the finalization of basis of allotment. Investors can check Brooks Laboratories IPO allotment status on the registrars website, Link Intime India Private Limited . Brooks Laboratories IPO refund dates are 30th November -0001.
Brooks Laboratories IPO is expected to be listed on 5th September 2011.
The upper price band for the Brooks Laboratories IPO is set at ₹ 100.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Brooks Laboratories IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Brooks Laboratories IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 18th August 2011. After submission, funds are blocked until the basis of allotment of Brooks Laboratories IPO is finalised.
The merchant banker for Brooks Laboratories IPO is D And A Financial Services Private Limited . D And A Financial Services Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Brooks Laboratories IPO RHP for further details.
The registrar for Brooks Laboratories IPO is Link Intime India Private Limited . Investors can go to Link Intime India Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Brooks Laboratories IPO through their official website or helpline.
Brooks Laboratories IPO was subscribed 1.60 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 63.00 Cr.
Avg IPO Size (Sector Based)
:
₹ 1,431.30 Cr.
Sector: Pharmaceutical
IPO so far:
23
Merchant Banker:
D And
IPO by BRLM so far:
2
City:
Punjab
IPO so far:
2
Revenue (annualised):
₹ 52.53 cr.
PE
Ratio:
17.33x
Average Sector PE Ratio: 27.10x
Brooks Laboratories IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Brooks Laboratories Financial Review Page
Merchant Banker(s) of Brooks Laboratories IPO: D And A Financial Services Private Limited
Brooks Laboratories IPO subscription was 1.60 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Brooks Laboratories IPO listed at a listing price of 60.20 against the offer price of 100.00.
The current market price of Brooks Laboratories is 150.96.
Why Us?
